55513-843 : Aimovig 140 mg/ml Subcutaneous Injection, Solution
NDC: | 55513-843 |
Labeler: | Amgen Inc |
Product Type: | Human Prescription Drug |
Drug Name: | Aimovig |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761077 |
Rev. Date: |
NDC Package Codes:
- 55513-843-00: 1 SYRINGE IN 1 CARTON (55513‑843‑00) > 1 ML IN 1 SYRINGE
- 55513-843-01: 1 SYRINGE IN 1 CARTON (55513‑843‑01) > 1 ML IN 1 SYRINGE
Active Ingredients:
- Erenumab
Dosage Strength:
- 140 mg/mL
Related Products:
Based on records with the same trade name.- 55513-840 Aimovig 70 mg/ml Subcutaneous Injection by Amgen Inc
- 55513-841 Aimovig 70 mg/ml Subcutaneous Injection by Amgen Inc
- 55513-842 Aimovig 140 mg/ml Subcutaneous Injection, Solution by Amgen Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 55513-842Next: 55513-880 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.